greenovation biotech gmbh

Greenovation develops plant-made next-generation therapeutics using its proprietary BryoTechnology platform. The company aims to optimize the production of highly-efficient glycoproteins for the treatment of rare diseases. Moss-aGal is Greenovation's lead product which exhibits optimized glycosylation patterns and superior features with respect to pharmacokinetics, pharmacodynamics and biodistribution in preclinical studies. This proprietary moss-expressed protein is intended for treatment of patients with Fabry Disease, a rare genetic lysosomal storage disorder that is caused by deficient activity subnormal or absent of the lysosomal enzyme α-galactosidase A. Greenovation is a privately owned biopharmaceutical company based in Heilbronn, Germany. It was founded in 1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunter Neuhaus. Today, Greenovation Biotech GmbH is majority-owned by Zukunftsfonds Heilbronn and L-EigenkapitalAgentur (Karlsruhe). https://www.greenovation.com/imprint.html https://www.greenovation.com/privacy-policy.html

Pharmaceuticals
,
Founded in unknown
11-50 employees

Greenovation develops plant-made next-generation therapeutics using its proprietary BryoTechnology platform. The company aims to optimize the production of highly-efficient glycoproteins for the treatment of rare diseases. Moss-aGal is Greenovation's lead product which exhibits optimized glycosylation patterns and superior features with respect to pharmacokinetics, pharmacodynamics and biodistribution in preclinical studies. This proprietary moss-expressed protein is intended for treatment of patients with Fabry Disease, a rare genetic lysosomal storage disorder that is caused by deficient activity subnormal or absent of the lysosomal enzyme α-galactosidase A. Greenovation is a privately owned biopharmaceutical company based in Heilbronn, Germany. It was founded in 1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunter Neuhaus. Today, Greenovation Biotech GmbH is majority-owned by Zukunftsfonds Heilbronn and L-EigenkapitalAgentur (Karlsruhe). https://www.greenovation.com/imprint.html https://www.greenovation.com/privacy-policy.html

Company Information

Industry
Pharmaceuticals
Company Type
Privately Held
Founded
unknown
Employee Range
11-50
Revenue Range
Not available

Location

Address
Hans-Bunte-Str. 19 Deutschland Freiburg
City
Region
Postal Code
79108
Country
Germany

Web Presence

Ready to automate your outreach?

Get unlimited access to our company database — complete with detailed profiles, funding info, and tech stacks — and start sending personalized emails with AI-powered follow-ups.

Frequently Asked Questions